Toxicology – Barbiturates

Core concept

Barbiturates are CNS depressants used mainly for seizure control, anesthesia, and sedation.

In overdose, the dominant toxicity is:

Progressive CNS depression → respiratory depression/apnea → hypotension → coma

Death is usually related to complications such as:

• Aspiration
• Respiratory failure
• Hypoxia
• Prolonged hypotension
• Pressure injury/rhabdomyolysis

Examples

Ultra-short acting

• Methohexital
• Thiopental
• Thiamylal

Short-acting

• Butabarbital
• Pentobarbital
• Secobarbital
• Hexobarbital

Long-acting

• Phenobarbital
• Mephobarbital
• Metharbital
• Primidone

Primidone is metabolized partly to phenobarbital and can therefore produce a similar toxic syndrome.

Pathophysiology

Barbiturates enhance GABA-mediated inhibitory neurotransmission in the CNS.

They bind to the GABA-A receptor complex and enhance chloride channel activity, producing:

Neuronal inhibition → sedation → coma → respiratory depression

Unlike benzodiazepines, severe barbiturate overdose can cause profound respiratory and cardiovascular depression.

Toxic Dose

There is no single universally toxic dose.

Important factors include:

• Specific barbiturate
• Acute versus chronic use
• Development of tolerance
• Coingestants
• Age
• Comorbid disease

In a barbiturate-naive patient, toxicity may occur not far above the therapeutic range, while chronic users may tolerate much larger doses.

Risk Factors

Greater toxicity may occur with:

• Advanced age
• Coingestion of other CNS depressants
• Alcohol
• Opioids
• Benzodiazepines
• Renal or hepatic dysfunction, depending on the agent

Drug interactions may alter phenobarbital concentrations.

Clinical Features

Neurologic

The major manifestation is dose-dependent CNS depression.

Early findings:

• Somnolence
• Ataxia
• Nystagmus
• Dysarthria
• Hyporeflexia

Progressive toxicity:

• Stupor
• Coma
• Loss of protective airway reflexes

Respiratory

• Hypoventilation
• Respiratory depression
• Apnea
• Aspiration risk

Respiratory depression is a major cause of morbidity and mortality.

Cardiovascular

• Hypotension
• Bradycardia may occur
• Cardiovascular collapse in severe poisoning

Hypotension may be especially prominent with rapid IV administration.

Temperature

Hypothermia is common in severe intoxication.

Dermatologic

Characteristic pressure-related bullae may develop during prolonged coma.

These are sometimes referred to as coma bullae.

Musculoskeletal

Prolonged immobilization can cause:

• Rhabdomyolysis
• Pressure necrosis
• Compartment syndrome

Gastrointestinal / Hepatic

Rare complications include:

• Hepatic injury
• Aspiration-related complications

Metabolic

• Hypoglycemia has occasionally been reported

Diagnosis

Diagnosis is based on:

Exposure history + typical sedative toxidrome + exclusion of other causes of coma

Laboratory Evaluation

Phenobarbital concentration

A serum phenobarbital level is useful when:

• Phenobarbital ingestion is suspected
• Primidone ingestion is suspected
• Severe or prolonged toxicity is present

Serial levels can help assess whether concentrations are rising or falling.

Additional investigations

In significant poisoning consider:

• Pulse oximetry
• Blood gas if respiratory depression is present
• Serum electrolytes
• BUN
• Creatinine
• Glucose
• Creatine kinase
• ECG

In intentional overdose also consider:

• Acetaminophen level
• Salicylate level
• Evaluation for other coingestants

If the cause of altered mental status is uncertain, investigate alternative neurologic, infectious, metabolic, and toxicologic causes.

Differential Diagnosis

Toxicologic causes

• Benzodiazepines
• Opioids
• Ethanol
• Valproate
• Carbamazepine
• Other sedative-hypnotics

Non-toxicologic causes

• Hypoglycemia
• Hypothermia
• Intracranial hemorrhage
• CNS infection
• Electrolyte disturbances
• Hypoxia

Treatment

1. Airway

Early airway protection is the priority.

Consider endotracheal intubation if the patient has:

• Severe CNS depression
• Loss of airway reflexes
• Hypoventilation
• Apnea
• Recurrent aspiration

2. Breathing

Provide:

• Supplemental oxygen
• Assisted ventilation when required
• Mechanical ventilation for respiratory failure

3. Circulation

Treat hypotension initially with:

• IV isotonic crystalloid

If hypotension persists despite adequate fluids:

• Use vasopressors according to standard critical-care practice

Gastrointestinal Decontamination

Activated charcoal

A single dose of activated charcoal may be considered after a substantial recent ingestion when:

• Presentation is early
• The airway is intact or protected
• Aspiration risk is acceptable

Gastric lavage

Although older references recommended gastric lavage for severe early presentations, routine gastric lavage is not generally recommended in contemporary poisoning management because potential harms usually outweigh benefit.

It is reserved for exceptional circumstances.

Multiple-Dose Activated Charcoal

Multiple-dose activated charcoal (MDAC) can enhance elimination of phenobarbital.

It may be considered in significant phenobarbital poisoning, particularly when:

• Toxicity is severe
• Serum levels remain high
• Gastrointestinal function is intact
• The airway is protected

MDAC is not useful for all barbiturates.

Avoid or discontinue it in:

• Ileus
• Gastrointestinal obstruction
• Unprotected airway
• Significant aspiration risk

Urinary Alkalinization

Phenobarbital is a weak acid, and urinary alkalinization can increase renal elimination.

However:

Urinary alkalinization is not routinely recommended as the primary enhanced-elimination strategy in modern phenobarbital poisoning, because clinical benefit is limited and MDAC or extracorporeal treatment may be more useful in severe cases.

If used, careful monitoring is required for:

• Potassium
• Sodium
• Fluid balance
• Acid-base status

Extracorporeal Treatment

Hemodialysis can substantially increase phenobarbital elimination and may be considered in severe long-acting barbiturate poisoning.

Potential indications include:

• Prolonged deep coma
• Severe respiratory depression requiring prolonged ventilation
• Persistent hypotension
• Severe toxicity with very high or rising concentrations
• Significant renal impairment
• Clinical deterioration despite supportive care

Modern high-efficiency hemodialysis is generally preferred over charcoal hemoperfusion when extracorporeal treatment is needed.

Antidote

There is no specific antidote for barbiturate poisoning.

Management is primarily:

Airway + ventilation + cardiovascular support + enhanced elimination when appropriate

Monitoring

Significantly poisoned patients should receive:

• Continuous cardiac monitoring
• Continuous oxygen saturation monitoring
• Serial neurologic assessment
• Serial blood pressure monitoring
• Temperature monitoring

Also monitor for:

• Aspiration
• Pressure injury
• Rhabdomyolysis
• Compartment syndrome
• Renal dysfunction

Admission

Hospital admission is appropriate when there is:

• Persistent sedation
• Ataxia preventing safe ambulation
• Respiratory depression
• Hypotension
• Coma
• Significant phenobarbital toxicity
• Rising drug concentrations
• Serious coingestion

Severely poisoned patients generally require ICU management.

Prognosis

Large overdoses may cause prolonged coma lasting several days, particularly with long-acting agents such as phenobarbital.

Most patients recover with good supportive care unless complications develop.

Important complications include:

• Hypoxic brain injury
• Aspiration pneumonia
• Rhabdomyolysis
• Pressure necrosis
• Compartment syndrome
• Prolonged hypotension

Important Pitfalls

1. Failure to protect the airway

Profound CNS depression can rapidly cause:

• Aspiration
• Hypoxia
• Respiratory arrest

2. Assuming all coma is due to the barbiturate

Other causes of altered mental status must still be considered.

3. Missing pressure-related complications

Prolonged coma can cause:

• Coma bullae
• Rhabdomyolysis
• Compartment syndrome

4. Missing coingestants

Severe or fatal poisoning commonly involves additional CNS depressants.

High-Yield Toxicology Pearls

Barbiturate overdose = coma + respiratory depression + hypotension + hypothermia

Think:

Sedative toxidrome + nystagmus/hyporeflexia + apnea + hypotension

Key points:

• Mechanism: enhancement of GABA-A activity
• Major toxicity: CNS and respiratory depression
• Severe overdose may cause coma and apnea
• Hypothermia and hypotension are common
• Pressure-related bullae and rhabdomyolysis may occur
• No specific antidote
• Main treatment: aggressive supportive care
• Phenobarbital levels are useful when phenobarbital or primidone is involved
• Multiple-dose activated charcoal may enhance phenobarbital elimination
• Hemodialysis may be useful in severe phenobarbital poisoning
• Early airway management is critical to prevent aspiration and hypoxic injury